Pulmonary diseases pose a major health problem worldwide with millions of affected individuals and dire economic impact.

The NIH is picking up Robert F. Kennedy Jr.’s argument that a healthy immune system can keep even pandemic germs at bay.

Private sector leaders, philanthropists, and global health experts convened today at the B20 Global Health Breakout, held on the margins of the G20 Leaders' Summit, to spotlight a new wave of ...

In simulations across the country, students are practicing pandemic scenarios. The results are often unsettling.

Battles between the Trump administration and academic institutions are putting important biomedical advances in limbo.

Unraveling mechanisms underlying post-acute SARS-CoV-2 sequelae (long COVID) and finding therapeutic solutions require a full understanding of the causative role of SARS-CoV-2 persistence and/or ...

Single-cell RNA sequencing identified distinct immune profiles in extrapulmonary TB, linking interferon–IL-1 signaling to ...

Scientists at MIT have identified 24 protein fragments that could form a new tuberculosis vaccine, offering a potential breakthrough. This next-genera ...

The Trump administration's new health aid strategy aims to require countries to share critical pathogen data with the U.S. in exchange for funding, raising concerns about fairness and equity in global ...

Scientists at the Massachusetts Institute of Technology (MIT) may be on the cusp of making a new vaccine to combat a rise in the world's deadliest disease, which takes 1million lives worldwide.

Findings are consistent with previous studies of a similarly constructed licensed Ebolavirus vaccine.

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.73 billion (USD 11.6 million1) in four R&D projects for the development of diagnostics and ...